Using Phage Therapy to Control Staphylococcus aureus
Author Information
Author(s): Vandersteegen Katrien, Mattheus Wesley, Ceyssens Pieter-Jan, Bilocq Florence, De Vos Daniel, Pirnay Jean-Paul, Noben Jean-Paul, Merabishvili Maia, Lipinska Urszula, Hermans Katleen, Lavigne Rob
Primary Institution: Katholieke Universiteit Leuven
Hypothesis
Can phage ISP effectively control Staphylococcus aureus infections, including MRSA strains?
Conclusion
Phage ISP shows significant potential for treating Staphylococcus aureus infections, including MRSA, with no observed adverse effects in rabbits.
Supporting Evidence
- Phage ISP was effective against 86% of tested Staphylococcus aureus strains.
- No toxic or virulence-associated proteins were found in the ISP genome.
- ISP administration in rabbits showed no adverse effects.
Takeaway
Scientists are exploring a virus called phage ISP that can kill harmful bacteria like Staphylococcus aureus, which is often resistant to antibiotics.
Methodology
The study involved host range screening, genome analysis, and in vivo safety assessments in rabbits.
Limitations
The study's findings may not be generalizable to all strains of Staphylococcus aureus or other bacterial pathogens.
Participant Demographics
The study included various strains of Staphylococcus aureus from human and animal sources.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website